Skip to main content

Market Overview

Transenterix Falls 10%


Shares of Transenterix Inc (NYSE: TRXC), a medical device company that focuses on robotic assisted surgery, were trading lower by around 15 percent early Wednesday morning after the company announced on Tuesday it plans to offer and sell up to $43.56 million of its common stock.

Transenterix noted that it plans on using the net proceeds from the offering for "payment of obligations as they come due, including scheduled payments under our existing loan agreement and installment payments to SOFAR under the ALF-X Acquisition agreement, research and development and sales, marketing and commercialization activities related to the ALF-X System and the SurgiBot System, strategic acquisitions of assets or technologies, and for working capital purposes. "

In a separate announcement on Wednesday, Transenterix announced that it has successfully completed its response to the U.S. Food and Drug Administration related to its pending 510(k) application submitted for clearance of its SurgiBot System.


Related Articles (TRXC)

View Comments and Join the Discussion!

Posted-In: ALF-X Robotic Surgery SOFAR SurgiBot TransenterixNews Financing Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at